IDR 2360.0
(-2.07%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 1555.38 Billion IDR | -2.7% |
2022 | 1632.59 Billion IDR | -17.59% |
2021 | 1926.29 Billion IDR | 48.4% |
2020 | 1361.48 Billion IDR | 13.85% |
2019 | 1178.75 Billion IDR | 19.05% |
2018 | 905.73 Billion IDR | -2.33% |
2017 | 1003.82 Billion IDR | -3.24% |
2016 | 1009.94 Billion IDR | 22.27% |
2015 | 842.12 Billion IDR | 15.4% |
2014 | 679.25 Billion IDR | 19.2% |
2013 | 563.24 Billion IDR | 3524.49% |
2012 | 15.72 Billion IDR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q3 | 415.46 Billion IDR | -9.01% |
2024 Q1 | 448.51 Billion IDR | 22.8% |
2024 Q2 | 455.23 Billion IDR | 2.34% |
2023 Q2 | 343.69 Billion IDR | -1.53% |
2023 Q4 | 316.53 Billion IDR | -17.16% |
2023 Q3 | 382.1 Billion IDR | 11.17% |
2023 FY | - IDR | -2.7% |
2023 Q1 | 349.03 Billion IDR | -6.82% |
2022 FY | - IDR | -17.59% |
2022 Q3 | 346.29 Billion IDR | -7.19% |
2022 Q4 | 374.59 Billion IDR | 8.17% |
2022 Q2 | 373.1 Billion IDR | -8.4% |
2022 Q1 | 407.31 Billion IDR | -8.16% |
2021 Q4 | 443.5 Billion IDR | 12.1% |
2021 FY | - IDR | 48.4% |
2021 Q3 | 395.62 Billion IDR | -15.94% |
2021 Q2 | 470.64 Billion IDR | -8.07% |
2021 Q1 | 511.96 Billion IDR | 13.46% |
2020 FY | - IDR | 13.85% |
2020 Q4 | 451.22 Billion IDR | 30.98% |
2020 Q1 | 303.43 Billion IDR | 19.53% |
2020 Q2 | 128.46 Billion IDR | -57.66% |
2020 Q3 | 344.49 Billion IDR | 168.17% |
2019 Q4 | 253.85 Billion IDR | -11.15% |
2019 FY | - IDR | 19.05% |
2019 Q3 | 285.7 Billion IDR | 12.31% |
2019 Q2 | 254.39 Billion IDR | -10.55% |
2019 Q1 | 284.4 Billion IDR | 34.18% |
2018 Q2 | 186.72 Billion IDR | -21.41% |
2018 Q1 | 237.59 Billion IDR | 20.96% |
2018 FY | - IDR | -2.33% |
2018 Q4 | 211.95 Billion IDR | -21.34% |
2018 Q3 | 269.45 Billion IDR | 44.31% |
2017 Q1 | 253.55 Billion IDR | -27.86% |
2017 Q2 | 238.94 Billion IDR | -5.76% |
2017 FY | - IDR | -3.24% |
2017 Q4 | 196.42 Billion IDR | -17.61% |
2017 Q3 | 238.4 Billion IDR | -0.23% |
2016 Q1 | 209.92 Billion IDR | 15.52% |
2016 FY | - IDR | 22.27% |
2016 Q4 | 351.46 Billion IDR | 97.2% |
2016 Q3 | 178.23 Billion IDR | -18.54% |
2016 Q2 | 218.78 Billion IDR | 4.22% |
2015 Q3 | 180.7 Billion IDR | -17.63% |
2015 Q4 | 181.72 Billion IDR | 0.56% |
2015 FY | - IDR | 15.4% |
2015 Q1 | 202.02 Billion IDR | 17.4% |
2015 Q2 | 219.39 Billion IDR | 8.59% |
2014 Q2 | 169.79 Billion IDR | -4.66% |
2014 Q4 | 172.08 Billion IDR | 8.03% |
2014 FY | - IDR | 19.2% |
2014 Q3 | 159.29 Billion IDR | -6.19% |
2014 Q1 | 178.08 Billion IDR | 0.0% |
2013 FY | - IDR | 3524.49% |
2012 FY | - IDR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
PT Bundamedik Tbk | 223.9 Billion IDR | -594.656% |
PT Metro Healthcare Indonesia Tbk | -7.68 Billion IDR | 20351.888% |
PT Medikaloka Hermina Tbk | 1584.42 Billion IDR | 1.833% |
PT Murni Sadar Tbk | 155.6 Billion IDR | -899.56% |
PT Famon Awal Bros Sedaya Tbk | 443.01 Billion IDR | -251.095% |
PT Royal Prima Tbk | 52.4 Billion IDR | -2867.849% |
PT Kedoya Adyaraya Tbk | 61.12 Billion IDR | -2444.731% |
PT Sarana Meditama Metropolitan Tbk | 323.18 Billion IDR | -381.267% |
PT Siloam International Hospitals Tbk | 2692.46 Billion IDR | 42.232% |
PT Sejahteraraya Anugrahjaya Tbk | 437.22 Billion IDR | -255.738% |